Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Device Daily Bulletin > More Good News From Medtronic’s Symplicity High Blood Pressure Trial

FDAnews Device Daily Bulletin

Sept. 17, 2012 | Vol. 9 No. 182

More Good News From Medtronic’s Symplicity High Blood Pressure Trial

An analysis of data from Medtronic’s Symplicity HTN 2 renal denervation trial showed that the procedure is a cost-effective way to treat resistant hypertension, or high blood pressure.
Mass Device

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Boston Scientific Presents Clinical Data at Digestive Disease Week Maquet Cardiovascular's Class I Ventilator Battery Recall Affects 90k Units Mobile Emergency Response Devices Not Only for the Elderly: Numera Nanotechnology Could Help Fight Diabetes

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.